Related Experiment Videos

Society for Maternal-Fetal Medicine Special Statement: Updated checklists for preeclampsia risk-factor screening to

, Jeny Ghartey, C Andrew Combs

    Pregnancy (Hoboken, N.J.)
    |August 14, 2026
    PubMed

    Insights

    Updated checklists help identify pregnant individuals who should receive prophylactic low-dose aspirin to prevent preeclampsia. These tools incorporate new recommendations to ensure appropriate candidates receive this important preventive care.

    Area of Science:

    • Obstetrics and Gynecology
    • Preventive Medicine
    • Maternal Health

    Background:

    • Preeclampsia is a significant risk for pregnant individuals, with prophylactic low-dose aspirin recommended for those with identified risk factors.
    • The Society for Maternal-Fetal Medicine (SMFM) previously issued checklists in 2020 to aid in risk factor screening.
    • The U.S. Preventive Services Task Force (USPSTF) updated guidelines in 2021, broadening eligibility for aspirin prophylaxis.

    Purpose of the Study:

    • To present updated SMFM checklists for preeclampsia risk-factor screening.
    • To incorporate the expanded recommendations from the 2021 USPSTF statement.
    • To provide guidance on implementing these checklists into clinical practice.

    Main Methods:

    • Review and synthesis of existing risk factors for preeclampsia.
    • Incorporation of updated screening criteria from the USPSTF.
    • Development of revised checklists for clinical use.
    • Inclusion of implementation strategies for healthcare providers.

    Main Results:

    • Updated checklists are now available, reflecting the latest evidence and recommendations for preeclampsia prevention.
    • The revised tools aim to improve the identification of individuals who would benefit from prophylactic low-dose aspirin.
    • Guidance is provided for integrating these checklists into routine obstetric care.

    Conclusions:

    • The updated SMFM checklists enhance the systematic screening for preeclampsia risk factors.
    • These tools support the appropriate and timely initiation of low-dose aspirin therapy in eligible pregnant individuals.
    • Implementation of these checklists can improve maternal outcomes by reducing preeclampsia incidence.

    Keywords:
    antiphospholipid syndromeautoimmune disordersdiabeteshypertensionimplementationin vitro fertilizationkidney diseasemultifetal pregnancypreventionsystemic lupus erythematosus

    Related Concept Videos

    Pre-Procedural Guidelines for Assessing Blood Pressure01:10

    Pre-Procedural Guidelines for Assessing Blood Pressure

    Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
    Mitral Valve Prolapse III: Nursing Management01:19

    Mitral Valve Prolapse III: Nursing Management

    The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...